Home › Blood Cancers › Texas
Blood Cancers clinical trials in Texas
49 studies for Blood Cancers are looking for participants at sites in Texas.
Cities in Texas
CD70.CAR for AML and Other CD70+ Leukemias
- Texas Children's Hospital, Houston
- The Methodist Hospital, Houston
RecruitingPhase 1
Up to age 75 · All sexes · Updated Nov 13, 2026 · NCT06345027Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Texas Oncology - Central/South Texas ( Site 8001), Austin
- Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas
- University of Texas MD Anderson Cancer Center ( Site 0007), Houston
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT03486873Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Texas Oncology-Austin Midtown, Austin
- Texas Oncology-Presbyterian Cancer Center, Dallas
- University of Texas, Houston
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07007312The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 to 39 · All sexes · Updated Nov 10, 2026 · NCT04551378Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- The Don and Sybil Harrington Cancer Center, Amarillo
- Audie L Murphy VA Hospital, San Antonio
RecruitingObservational study
All ages · All sexes · Updated Nov 4, 2026 · NCT04242095A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- MD Anderson Cancer Center - University of Texas, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07572006Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07809906Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Oct 30, 2026 · NCT07504458Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Oct 29, 2026 · NCT06131801Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT04728893Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Mays Cancer Center at UT Health San Antonio, San Antonio
Recruiting
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT05745285A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- The University of TX MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07424833Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07648264A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Md Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT07195916Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT04888338A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Cook Children's Medical Center, Fort Worth
- and 2 more
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Oct 6, 2026 · NCT05711667CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT03328078Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
- M D Anderson Cancer Center, Houston
RecruitingEarly phase 1
Ages 12 to 80 · All sexes · Updated Sep 23, 2026 · NCT04744116Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
- UT MD Anderson Cancer Center, Houston
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT07743476(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- M D Anderson Cancer Center, Houston
RecruitingPhase 2Healthy volunteers welcome
All ages · All sexes · Updated Sep 14, 2026 · NCT04984551Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- M D Anderson Cancer Center, Houston
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT02464696Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
- M D Anderson Cancer Center, Houston
RecruitingPhase 1
All ages · All sexes · Updated Sep 4, 2026 · NCT03425526Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Baylor Scott & White Health, Dallas
- MD Anderson, Houston
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- M D Anderson Cancer Center, Houston
RecruitingObservational study
All ages · All sexes · Updated Aug 21, 2026 · NCT01772771Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
- M D Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05110742Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
- M D Anderson Cancer Center, Houston
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06184321Expressive Writing for the Management of Stress in Cancer Survivors
- M D Anderson Cancer Center, Houston
Recruiting
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT04776941The Impact of COVID-19 on Pulmonary Procedures
- M D Anderson Cancer Center, Houston
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 10, 2026 · NCT05022446Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
- M D Anderson Cancer Center, Houston
RecruitingObservational study
All ages · All sexes · Updated Aug 10, 2026 · NCT05108519A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Irving
- UT San Antonio Mays Cancer, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06823167PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- University of Texas MD Anderson MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT06665100Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
- M D Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jul 16, 2026 · NCT04712539A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- and 5 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Improving Comprehensive Care of Cancer Patients
- Baylor College of Medicine, Houston
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT05323409Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT02074839Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT00991094From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.